Showing results (3161-3170 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|June 24, 2006
Low-grade gliomas in adultsJeanine T Grier, Tracy Batchelor
The Oncologist|September 15, 2006
Capecitabine: expanding options for the treatment of patients with early or locally advanced breast cancerAndrew Wardley
The Oncologist|September 15, 2006
HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapyChristian Jackisch
The Oncologist|August 5, 2005
Vaccines against human papillomavirus and cervical cancer: promises and challengesAli Mahdavi, Bradley J Monk
The Oncologist|June 7, 2021
Single-Center Analysis of Characteristics and Outcomes of De Novo, Concurrent, and Transformed Diffuse Large B-Cell LymphomaSanjal Desai, Mansi Chaturvedi, Rumaisa Hameed, et al.
The Oncologist|June 8, 2021
Causes of Death Following Nonmetastatic Colorectal Cancer Diagnosis in the U.S.: A Population-Based AnalysisAhmed M Afifi, Ahmed O Elmehrath, Inas A Ruhban, et al.
The Oncologist|June 28, 2022
Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer ForumJulia Lai-Kwon, Alyssa M Vanderbeek, Anna Minchom, et al.
The Oncologist|November 25, 2022
Management of Lung Cancer in the Patient with Interstitial Lung DiseaseAngela J Frank, Ibiayi Dagogo-Jack, Ioana A Dobre, et al.
The Oncologist|November 25, 2022
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study)Hiromichi Matsuoka, Junji Tsurutani, Yasutaka Chiba, et al.
The Oncologist|November 25, 2022
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsTony Z Zhuang, Deepak Ravindranathan, Yuan Liu, et al.
Pageof 571